Novak & Powell Financial Services’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Novak & Powell Financial Services’s Portfolio FBT Stock Details FBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$304K	Hold	1,512	–	–	0.16%	123
2025 Q4	$312K	Hold	1,512	–	–	0.16%	115
2025 Q3	$271K	Hold	1,512	–	–	0.14%	131
2025 Q2	$244K	Hold	1,512	–	–	0.17%	125
2025 Q1	$257K	Hold	1,512	–	–	0.16%	124
2024 Q4	$251K	Hold	1,512	–	–	0.15%	124
2024 Q3	$260K	Hold	1,512	–	–	0.15%	122
2024 Q2	$233K	Hold	1,512	–	–	0.14%	127
2024 Q1	$233K	Sell	1,512 -198	-12%	-$30.2K	0.17%	119
2023 Q4	$270K	Buy	+1,710	New	+$246K	0.18%	110

Other funds holding FBT

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return

BFG

Berger Financial Group Plymouth, Minnesota $1.79B AUM 15.72% 1-Year Est. Return

Novak & Powell Financial Services's FBT Position: Q1 2026 in Review

Novak & Powell Financial Services held its First Trust NYSE Arca Biotechnology Index Fund (FBT) position steady in Q1 2026 at 1,512 shares worth $304K. The position accounts for 0.16% of the portfolio, ranked #123.

Novak & Powell Financial Services first reported a position in FBT in Q4 2023 and has held it in 10 quarters since. The position peaked at $312K in Q4 2025. 307 funds tracked by Wall St. Rank hold FBT as of Q1 2026.

Novak & Powell Financial Services held 1,512 shares of First Trust NYSE Arca Biotechnology Index Fund worth $304K as of Q1 2026.
Novak & Powell Financial Services left its First Trust NYSE Arca Biotechnology Index Fund share count unchanged in Q1 2026.
First Trust NYSE Arca Biotechnology Index Fund made up 0.16% of Novak & Powell Financial Services's portfolio in Q1 2026, its #123 holding.
Novak & Powell Financial Services first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q4 2023 and has held it in 10 quarters since.
Novak & Powell Financial Services's First Trust NYSE Arca Biotechnology Index Fund position peaked at $312K in Q4 2025.
307 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q1 2026.

Based on Novak & Powell Financial Services's 13F filing for Q1 2026, filed 14 May 2026.